Encompass Health Corporation
EHC
Rang in Aktien
#1784
Encompass Health Corporation delivers a range of post-acute healthcare services... Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Aktienkurs
$121.91
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$12.03B
Veränderung (1 Tag)
-4.48%
Veränderung (1 Jahr)
-2.63%
Land
US
Handel Encompass Health Corporation (EHC)
Kategorie
Healthcare
Gewinn für Encompass Health Corporation (EHC)
Gewinn im Jun 2026 TTM: $1.03B
Laut den aktuellen Finanzberichten von Encompass Health Corporation betragen die aktuellen Gewinne des Unternehmens $1.03B. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $749.60M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $607.20M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Encompass Health Corporation von 2000 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $1.03B | 7.86% |
| 2025 | $953.00M | 27.13% |
| 2024 | $749.60M | 23.45% |
| 2023 | $607.20M | 34.69% |
| 2022 | $450.80M | -10.73% |
| 2021 | $505.00M | 43.10% |
| 2020 | $352.90M | -37.24% |
| 2019 | $562.30M | 14.01% |
| 2018 | $493.20M | -0.64% |
| 2017 | $496.40M | 2.99% |
| 2016 | $482.00M | 21.84% |
| 2015 | $395.60M | 2.25% |
| 2014 | $386.90M | -2.10% |
| 2013 | $395.20M | 16.24% |
| 2012 | $340.00M | 39.98% |
| 2011 | $242.90M | 27.91% |
| 2010 | $189.90M | 53.77% |
| 2009 | $123.50M | -36.83% |
| 2008 | $195.50M | -257.53% |
| 2007 | $-124.10M | -75.88% |
| 2006 | $-514.60M | 40.22% |
| 2005 | $-367.00M | 158.46% |
| 2004 | $-141.99M | -71.53% |
| 2003 | $-498.79M | 37.07% |
| 2002 | $-363.90M | 121.13% |
| 2001 | $-164.56M | -62.13% |
| 2000 | $-434.50M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $9.87B | 860.31% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 276.01% |
US
|
|
| $687.82M | -33.08% |
SA
|
|
| $1.25B | 21.29% |
BR
|
